Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase EARLY_PHASE1 2Phase 1/2 2Phase NA 1Phase 1 1

Status

Recruiting 3Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

NET 1Endocrine 1CNS 1

Conditions

Tumor Positron-Emission Tomography 1Neuroendocrine Tumors 1Neuroblastoma 1Medulloblastoma 1Carcinoid Tumor 1

Interventions

Cyclophosphamide 142Gemcitabine 129Paclitaxel 125Radiotherapy 119Carboplatin 112Cisplatin 111pembrolizumab 110Nivolumab 106Docetaxel 90Rituximab 86Lenalidomide 77Dexamethasone 76Cytarabine 69Bevacizumab 64Fluorouracil 63Etoposide 63Oxaliplatin 62Filgrastim 59Peripheral Blood Stem Cell Transplantation 58Everolimus 58Capecitabine 58fludarabine phosphate 57Doxorubicin 56Temozolomide 55Prednisone 54Irinotecan 53Cetuximab 50fludarabine 48Ipilimumab 48Erlotinib Hydrochloride 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Completed × gallium Ga 68 dotatate × Clear all
NCT05990998 2024-02-26

A Head-to-head Comparison of [68Ga]Ga-FAPI and [68Ga]Ga-TATE PET/CT in Patients With Nasopharyngeal Carcinoma: a Single-center, Prospective Study

First Affiliated Hospital of Fujian Medical University

Phase 1/2 Completed
38 enrolled

Tumor Positron-Emission Tomography

NCT01619865 2021-07-27

GA-68

University of Iowa

Phase 1/2 Completed
223 enrolled 11 charts
CNSEndocrineNET

Carcinoid Tumor, Medulloblastoma, Neuroblastoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡